The clinical immunobiology of interleukin-2: potential modified uses for improved cancer treatment.

Voss SD, Weil-Hillman G, Hank JA, Sosman JA, Sondel PM
Bull N Y Acad Med. 1989 65 (1): 93-110

PMID: 2690996 · PMCID: PMC1807781

MeSH Terms (11)

Animals Cytotoxicity, Immunologic Drug Evaluation Forecasting Histocompatibility Antigens Humans Immunotherapy Interleukin-2 Killer Cells, Lymphokine-Activated Lymphocyte Activation Neoplasms

Connections (1)

This publication is referenced by other Labnodes entities:

Links